Phase 2b showed 11.1% at 2.4 mg at 18 weeks, superior to liraglutide 3 mg
During pregnancy and delivery hemorrhoids can occur due to anal pressure, constipation, and pushing
In 2023, an estimated 13.3 million Medicare beneficiaries enrolled in Parts A and B had obesity or overweight, based on having BMI of 27 or more recorded in claims or encounter data, or 24% of Medicare beneficiaries overall (Figure 1)
It is essential to emphasise that any use of GLP-1 medications in Hashimoto's patients would be off-label unless the individual also meets criteria for type 2 diabetes or obesity treatment according to the medication's SmPC
By removing the psychological and practical barriers associated with injectable treatments, oral GLP-1s have the potential to reposition obesity care as a routine, chronic intervention rather than a specialist-led, escalation therapy
PMID: 15565145 | doi:10.1038/nature03000 Malinda KM et al